Hexa Dental
Hexa ImplanTITAN Dual-Cure 4:1 Implant Cement, 5 mL Automix Syringe & 10 Mixing Tips
$140.00
- 1 +
ADD TO CART
Product Description ▼
Hexa ImplanTITAN is a high-performance, dual-curing resin-based implant cement specifically formulated for the semi-permanent fixation of implant-retained crowns and bridges. This advanced cement provides a secure hold with the added benefit of easy retrievability for future maintenance or adjustments, striking the ideal balance between retention and access.
Key Product Features & Benefits
- Dual-Cure Versatility: The dual-cure mechanism allows the cement to set both chemically and with light activation, ensuring a complete and reliable cure even in deep or opaque areas where light penetration is limited.
- Optimal Retention and Retrievability: Engineered with reinforced adhesion and compressive strength for secure, long-term use, while still allowing for non-destructive removal of the restoration if needed.
- Accurate Seating: Features a very low film thickness to promote precise positioning and complete seating of the restoration with minimal displacement, which is essential for accurate occlusion.
- Easy Excess Removal: Excess cement can be effortlessly removed during the material's initial gel phase (around 2-2.5 minutes at body temperature), helping to ensure a seamless application and minimizing the risk of residual subgingival cement that can cause peri-implant complications.
- High Compatibility: Compatible with all material combinations, including titanium, zirconia, and resin bases.
- Natural Aesthetics: A natural-opaque color ensures excellent esthetic results.
- Convenient Automix System: The 4:1 automix syringe delivery system provides a consistent, bubble-free, and homogenous mix every time, streamlining your workflow and minimizing waste.
Intended Use
ImplanTITAN is primarily indicated for:
- Cement-retained single-unit implant crowns
- Implant-supported short-span bridges
- Restorations on customized or small abutments where surface area is limited
- Situations where future access to the implant interface is a possibility
